For the most part, developing new medical technologies is a huge benefit to people. Take for instance the smart pill that the U.S. Food and Drug Administration (FDA) just approved, which is meant to monitor if patients are sticking to their medication schedule. While incredibly useful, it could also allow entities like the U.S. government to spy on its citizens even more intrusively than it does now.
No one likes to be spied on and yet this is exactly what concerned privacy groups are saying could happen with the digital pill that the FDA just approved for use. Called the Abilify MyCite, the pill comes with sensors that basically indicate if patients just took their medication, Futurism reports.
Abilify is a drug used to treat neurological conditions such as schizophrenia and bipolar disorders. The sensor is embedded in the pill, where it will send out a signal once it comes in contact with the stomach. This signal will be picked up by a patch on the patient’s left rib cage, which will then notify the monitoring personnel via the accompanying app.
The information that the sensors can send out can include the dosage, the exact time when the pill was taken, and even what the patient was doing at the time. Because of how intrusive the data mining process appears, groups concerned about potential abuses are speaking out. They are especially worried about potential punitive actions against patients who are committing what’s called nonadherence.
Basically, nonadherence or noncompliance refers to patients not taking their medication as they are supposed to. This leads to patients getting sicker, which then leads to higher medical costs due to the increased medical attention that they need. Apparently, this particular trend costs $100 billion a year, the New York Times reports.
There’s also the concern of medical professionals that a smart pill could lead to a feeling of coercion on the part of the patients. Subjects could feel pressured to take their medication because their doctors are monitoring them.


Apple Alerts EU Regulators That Apple Ads and Maps Meet DMA Gatekeeper Thresholds
Amazon and Google Launch New Multicloud Networking Service to Boost High-Speed Cloud Connectivity
Coupang Apologizes After Massive Data Breach Affecting 33.7 Million Users
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave
Intel Boosts Malaysia Operations with Additional RM860 Million Investment
AI-Guided Drones Transform Ukraine’s Battlefield Strategy
OpenAI Moves to Acquire Neptune as It Expands AI Training Capabilities
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts
Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy
Baidu Cuts Jobs as AI Competition and Ad Revenue Slump Intensify
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Microchip Technology Boosts Q3 Outlook on Strong Bookings Momentum
Morgan Stanley Boosts Nvidia and Broadcom Targets as AI Demand Surges
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
TSMC Accuses Former Executive of Leaking Trade Secrets as Taiwan Prosecutors Launch Investigation 



